The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenus Share News (GNS)

Share Price Information for Genus (GNS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,846.00
Bid: 1,826.00
Ask: 1,840.00
Change: 0.00 (0.00%)
Spread: 14.00 (0.767%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,846.00
GNS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Genus Posts "Very Strong" Interim Results Despite Covid-19 Impact

Thu, 25th Feb 2021 09:42

(Alliance News) - Genus PLC on Thursday reported a "very strong" performance" and made "good" strategic progress in the first half of its 2021 financial year.

The Basingstoke, Hampshire-based company sells products made using biotechnology to cattle and pig farmers. It recorded revenue for the six moths ended December 31 of GBP285.7 million, a rise of 6% from GBP270.7 million in 2019.

Pretax profit for the period was GBP38.7 million, a substantial increase of 27% from GBP30.4 million in 2019.

Genus said these increases are due to a "strong" revenue growth of 6% in actual currency and 11% in constant currency. Its porcine genetics business saw an 8% increase, while its bovine genetics business grew by 17%, particularly in Brazil, Russia, India and China.

As a result of "strong earnings growth and cash flow generation", the company has declared an interim dividend of 10.3 pence, which is a 10% increase from 9.4p the previous year.

Shares in Genus were down 4.9% at 4,984.98p in London on Thursday.

"The group continued to show its resilience during the Covid-19 pandemic. Both PIC and ABS grew adjusted operating profits in double digits, with China, Brazil, India and Russia, being notably high growth markets. The porcine genetics business' expansion in China was significant, gaining share with large producers that have been re-stocking following the spread of African Swine Fever in 2019. Europe's growth was also very strong reflecting success with key accounts, leveraging our genetics and supply chain," said Chief Executive Stephen Wilson.

"The bovine genetics business' volume growth in the half was a record, driven by the continued success of Sexcel, and strong performance by our proprietary NuEra beef business. Latin America, Europe and Asia all grew strongly, and ABS's adjusted operating margin improved through better product mix and operating leverage," Wilson added.

Looking ahead, Genus said it will remain "resilient" as the the Covid-19 pandemic continues and expects trading to be in line with its 2021 expectations.

"In the second half of the 2021 fiscal year, we expect that growth will be lower and there are increased currency headwinds. Nevertheless, Genus continues to have significant growth opportunities and the board's expectations remain unchanged for the full year," Wilson said.

By Zoe Wickens; zoewickens@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
25 Feb 2021 09:05

Genus reports strong interim results

(Sharecast News) - Animal genetics company Genus reported a record adjusted profit before tax in its interim results on Thursday, as revenue in its porcine genetics business 'PIC' rose 8%.

Read more
18 Feb 2021 15:58

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
18 Jan 2021 11:59

LONDON MARKET MIDDAY: US Holiday Leads To Quiet Session; Airlines Slip

LONDON MARKET MIDDAY: US Holiday Leads To Quiet Session; Airlines Slip

Read more
18 Jan 2021 09:34

UK BROKER RATINGS SUMMARY: Land Securities And Dixons Get Upgrades

UK BROKER RATINGS SUMMARY: Land Securities And Dixons Get Upgrades

Read more
18 Jan 2021 08:40

LONDON MARKET OPEN: Soft Start As China Retail Sales Signal Weakness

LONDON MARKET OPEN: Soft Start As China Retail Sales Signal Weakness

Read more
18 Jan 2021 08:35

Genus Set To Post Strong Interim Growth, Beat Prior Annual Guidance

Genus Set To Post Strong Interim Growth, Beat Prior Annual Guidance

Read more
18 Jan 2021 07:43

LONDON MARKET PRE-OPEN: Spirent Expects Earnings Growth For 2020

LONDON MARKET PRE-OPEN: Spirent Expects Earnings Growth For 2020

Read more
4 Dec 2020 16:06

UK Dividends Calendar - Next 7 Days

UK Dividends Calendar - Next 7 Days

Read more
2 Dec 2020 08:40

Covid-19 vaccines trigger new bullmarket, Liberum says

(Sharecast News) - The development of successful Covid-19 vaccines has set off a fresh bull market for UK shares that will last several years, Liberum analysts said.

Read more
25 Nov 2020 13:38

Wednesday broker round-up

(Sharecast News) - Codemasters Group: Berenberg downgrades to hold with a target price of 485p.

Read more
25 Nov 2020 11:56

LONDON MARKET MIDDAY: Pre-Thanksgiving Markets Lull; Sunak Review Due

LONDON MARKET MIDDAY: Pre-Thanksgiving Markets Lull; Sunak Review Due

Read more
25 Nov 2020 10:44

UK WINNERS & LOSERS SUMMARY: GoCo Up, Future Down After Takeover Offer

UK WINNERS & LOSERS SUMMARY: GoCo Up, Future Down After Takeover Offer

Read more
25 Nov 2020 10:10

Genus Reports Strong Trading Growth Depsite Covid-19 Pandemic Impact

Genus Reports Strong Trading Growth Depsite Covid-19 Pandemic Impact

Read more
25 Nov 2020 09:28

UK BROKER RATINGS SUMMARY: Jefferies Upgrades Antofagasta And Glencore

UK BROKER RATINGS SUMMARY: Jefferies Upgrades Antofagasta And Glencore

Read more
25 Nov 2020 08:31

Genus sees 'good momentum' carry over into new trading year

(Sharecast News) - Animal genetics company Genus said on Wednesday that "good momentum" seen at the end of the previous trading year had carried over into the current one.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.